Sanofi (Sanofi) Total Tax Payable

: $408 Mil (As of Jun. 2023)

View and export this data going back to 2002. Start your Free Trial

Sanofi's Total Tax Payable for the quarter that ended in Jun. 2023 was $408 Mil.

Sanofi's quarterly Total Tax Payable increased from Jun. 2022 ($468 Mil) to Dec. 2022 ($1,053 Mil) but then declined from Dec. 2022 ($1,053 Mil) to Jun. 2023 ($408 Mil).

Sanofi's annual Total Tax Payable increased from Dec. 2021 ($833 Mil) to Dec. 2022 ($1,053 Mil) and increased from Dec. 2022 ($1,053 Mil) to Dec. 2023 ($1,082 Mil).

Sanofi Total Tax Payable Historical Data

The historical data trend for Sanofi's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Tax Payable

687.78

896.59

832.77

1,052.97

1,081.79

Sanofi Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Tax Payable																832.77	468.29	1,052.97	408.45	1,081.79

Sanofi Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Sanofi Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Sanofi's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Sanofi (Sanofi) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (NAS:SNY) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

SNYNF:USA SNY:Mexico SANF:Italy 0A2V:UK SANp:UK 0O59:UK SAN:France SNW:Germany SNW2:Germany SNW:Germany SNW:Germany SNW2:Germany SNW:Germany SANO:Austria

Address

46, avenue de la Grande Armée, Paris, FRA, 75017

Website

https://www.sanofi.com

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 15% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.